Cervix cancer

ABSTRACT

A study of cervical cancer took place at the Maternity Hospital of Damascus University from 1990 to 1995. A total of 102 patients were treated, the mean age was 46.6 years, 55% of patients were 40-59 years old. 30.4% were less than 40 years old and 14.6% were older than 60 years old. Vaginal bleeding was the main symptom especially post menopausal bleeding 31.4% and postcoital bleeding 27.5%. 85.2% of the cases were stage I and stage II of cancer cervix. 88.2% of all cases of cancer cervix were squamous cell carcinoma and 10.2% were adenocarcinoma. The most common among squamous cell carcinoma was large cell non keratinizing 54.7, then large cell keratinzing 26.6%, and at the end small cell 18.8%. The incidence of pelivc nodes metastases were high in small cell squamous cell carcinoma 75%, while it was 31.4% in non keratinzing large cell and 17.6% in large cell keratinizing. The dominating treatment modality for cervix carcinoma in our hospital was surgery 78.5% alone or combined with radiotherapy. Surgery alone was adequate in 41.2% of cases. During follow up of 83 patients with cancer cervix, there were 26.5% deaths of cancer, 19.3% patients were lost, and survival rate 53%. The survival rate after surgery was the highest among all other kinds of treatment. The stage of cervical cancer has been shown to be an important prognostic indication, the incidence of nodal metastases for stage I, II were 20% and 35.7% respectively. The incidence of positive vaginal margins was 6.7% for stage I and l6.7% for stage II